scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.STR.23.11.1573 |
P698 | PubMed publication ID | 1332219 |
P50 | author | Niklas Marklund | Q42292408 |
Tommy Olsson | Q43130969 | ||
Yngve Gustafson | Q44983538 | ||
P2093 | author name string | B Näsman | |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1573-1576 | |
P577 | publication date | 1992-11-01 | |
P1433 | published in | Stroke Journal | Q7624282 |
P1476 | title | Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke | |
P478 | volume | 23 |
Q34546081 | Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study |
Q38571964 | Aphasia and the neuropsychobiology of stress |
Q58583594 | Association between Serum Copeptin and Stroke in Rural Areas of Northern China: A Matched Case-Control Study |
Q34293461 | At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response |
Q36472245 | Blood pressure management in acute stroke: a long-standing debate. |
Q38142904 | Changes in hypothalamus-pituitary-adrenal axis following transient ischemic attack |
Q36951390 | Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: A critical literature review |
Q48112819 | Confused and disturbed behavior in the elderly following silent frontal lobe infarction |
Q30722908 | Conventional magnetic resonance imaging of acute stroke |
Q47594918 | Copeptin Levels Do Not Correlate With Cross-Clamping Time in Patients Undergoing Carotid Endarterectomy Under General Anesthesia. |
Q43207505 | Copeptin: a novel, independent prognostic marker in patients with ischemic stroke |
Q26864822 | Cortisol levels and the severity and outcomes of acute stroke: a systematic review |
Q92461825 | Delirium Assessment in Acute Stroke: A Systematic Review and Meta-Analysis of Incidence, Assessment Tools, and Assessment Frequencies |
Q36533134 | Early poststroke seizures |
Q34423717 | Endocrine abnormalities and outcome of ischaemic stroke |
Q46868198 | Endocrine alterations in critically ill patients with stroke during the early recovery period |
Q48125498 | Environmental enrichment alters nerve growth factor-induced gene A and glucocorticoid receptor messenger RNA expression after middle cerebral artery occlusion in rats |
Q35561202 | High serum cortisol level is associated with increased risk of delirium after coronary artery bypass graft surgery: a prospective cohort study |
Q40584312 | Hypercortisolemia in acute stroke is related to the inflammatory response |
Q48762561 | Hypercortisolism after stroke--partly cytokine-mediated? |
Q36164892 | Hypothalamic-pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury |
Q30250270 | Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy |
Q59137244 | Improvement of Pituitary Function after Carotid Revascularization in Patients with Abnormal Cerebral Perfusion - A Pilot Study |
Q48189929 | Infarct volume and functional outcome after pre- and postoperative administration of metyrapone, a steroid synthesis inhibitor, in focal brain ischemia in the rat. |
Q37035033 | Inflammation in acute ischemic stroke and its relevance to stroke critical care. |
Q30620565 | Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. |
Q38805424 | Intracranial hemorrhage in cancer patients treated with anticoagulation |
Q44342696 | Ischemia/reperfusion-induced changes of hypothalamic-pituitary-adrenal (HPA) activity is opioid related in Sprague-Dawley rat. |
Q24794382 | Loss of circadian rhythm of blood pressure following acute stroke |
Q44930751 | Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke |
Q48492010 | Metyrapone reduces rat brain damage and seizures after hypoxia-ischemia: an effect independent of modulation of plasma corticosterone levels? |
Q35474349 | Neuroendocrine changes in patients with acute space occupying ischaemic stroke |
Q39718284 | Neuroendocrine changes in patients with spontaneous supratentorial intracerebral hemorrhage |
Q43445834 | Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat. |
Q48287980 | Neurosteroids, brain damage, and mental illness |
Q34708532 | Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke |
Q57059254 | Rationale and design of a randomized trial of early intensive blood pressure lowering on cerebral perfusion parameters in thrombolysed acute ischemic stroke patients |
Q49290734 | Relationship between serum cortisol level and degree of false lumen thrombosis in patients with uncomplicated type B aortic dissection |
Q34998508 | Retracted: Cortisol as a Prognostic Marker of Short-Term Outcome in Chinese Patients with Acute Ischemic Stroke |
Q44992611 | Salivary cortisol, a biological marker of stress, is positively associated with 24-hour systolic blood pressure in patients with acute ischaemic stroke |
Q57199157 | Selective Losses of Brainstem Catecholamine Neurons After Hypoxia-Ischemia in the Immature Rat Pup |
Q44821241 | Serum interleukin-6 predicts cortisol release in acute stroke patients. |
Q35067610 | The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region |
Q44855264 | The low-dose corticotropin stimulation test in acute traumatic and non-traumatic brain injury: incidence of hypo-responsiveness and relationship to outcome |
Q38178714 | The role of neuroendocrine pathways in prognosis after stroke |
Q37895672 | Therapy for prevention of post-stroke depression |